查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844201

尿道结石管理设备市场（按设备类型、治疗类型、设备材料、应用和最终用户划分）—2025-2032 年全球预测

Urolithiasis Management Devices Market by Device Type, Treatment Type, Device Material, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，尿道结石管理设备市场将成长 9.037 亿美元，复合年增长率为 7.93%。

主要市场统计数据
基准年2024年 4.9076亿美元
预计2025年 5.2703亿美元
预测年份：2032年 9.037亿美元
复合年增长率（%） 7.93%

全面介绍当前临床实践、技术创新和相关人员的压力，这些因素影响尿道结石治疗设备的开发和采用

尿路结石管理设备正处于技术创新、临床通讯协定发展和医疗服务模式变革的动态交会点。过去十年，诊断影像、内视镜视觉化和腔内能量传输技术的不断进步，共同拓展了治疗方案，并优化了病患照护路径。本简介概述了当前的发展态势，重点介绍瞭如何定制设备设计、材料科学和操作人体工学，以最大限度地降低侵入性，同时优化结石去除和患者康復。

如今，临床医生优先考虑能够提供可重复结果且安全性可预测的设备，而製造商则透过专注于模组化、一次性使用选项以及与数位平台整合以提供操作指导来应对这一挑战。付款人和医疗系统要求在吞吐量和术后资源利用率方面取得显着提升，这正在塑造采购偏好。总体而言，该产业的特点是技术快速迭代、更注重用户体验，以及不断调整价值提案以满足临床和经济绩效要求。

设备小型化、一次性技术和整合数位平台的转型正在再形成程式路径和采用

尿道结石治疗领域正在经历变革时期，这得益于设备小型化、能量输送方式以及数位诊断整合技术的进步。微型输尿管镜和软式内视镜正在扩大内视镜治疗结石的范围，并减少对侵入性更强的手术的依赖。同时，腔内碎石技术的改进，尤其是在平衡碎石效率和热安全性的雷射平台方面的改进，正在改变手术流程，并增加可在门诊完成的病例数量。

除了单纯的设备性能之外，为了解决感染控制问题并简化灭菌工作流程，一次性和一次性使用技术也呈现明显的趋势。提供程式分析和影像增强工具的数据驱动型设备的兴起，为结果追踪和操作员培训创造了机会。此外，监管预期和报销框架也在同步发展，要求製造商不仅要证明临床有效性，还要证明可衡量的营运效益。

分析到 2025 年不断变化的关税制度和贸易重组将如何影响整个医疗设备供应链的筹资策略、成本结构和采购弹性。

2025年关税政策和国际贸易动态的变化，为製造商、供应商和医疗保健采购负责人带来了新的营运考量。某些医疗设备零件的关税上调，加上地缘政治发展引发的供应链重组，迫使相关人员重新评估筹资策略和成本结构。重要的是，这些贸易措施凸显了建立一个灵活的采购框架的必要性，该框架应能有效应对跨境成本和前置作业时间的波动。

为了应对这种情况，许多公司正在多元化其供应商基础，并评估近岸外包机会，以降低其受进口相关波动影响的风险。医疗设备设计人员也在重新审视其物料清单选择，倾向于选择贸易壁垒较低的本地可用材料和子组件。临床护理提供者的采购团队越来越多地纳入总拥有成本分析，其中考虑了关税影响、物流和库存缓衝，这些因素会影响采购週期以及与製造商和经销商的合约安排。

深度细分洞察，将产品类型、治疗方式、材料、临床应用和最终用户需求与策略性产品定位连结起来

有效的細項分析能够揭示临床需求、技术适用性和购买行为之间的交集。依设备类型，本研究涵盖导管导引线、碎石机、支架和输尿管镜。导管导引线着重于尖端控制和涂层技术，碎石机追求高效节能的碎石效果，同时最大限度地减少对侧支组织的影响，支架则透过材料科学优化患者舒适度和植入性，而输尿管镜则在光学性能与灵活性和耐用性之间取得平衡。依治疗类型，本研究涵盖体外震波碎石术、体内碎石术和经皮肾镜碎石术市场，每种治疗方式都对能量输送、接取设备和影像整合有着独特的设备需求。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 人工智慧演算法的整合度不断提高，以实现肾结石的自动检测和治疗计划
  • 一次性输尿管镜需求激增，以降低交叉污染的风险
  • 超音波和雷射碎石技术的进步使得结石破碎速度更快
  • 扩大远端医疗和远端患者监护用于术后尿道结石护理
  • 开发生物可吸收支架，最大程度减少患者不适并减少二次手术
  • 增加对可携式超音波导引碎石设备的投资，用于照护现场
  • 透过 3D 列印的患者特定肾臟模型更重视个人化治疗途径

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章尿道结石管理设备市场（依设备类型）

  • 导管导引线
  • 碎石机
  • 支架
  • 输尿管镜

第九章尿道结石管理设备市场（依治疗类型）

  • 体外震波碎石术
  • 体内碎石术
  • 经皮肾镜取石术

第 10 章尿道结石管理设备市场（依设备材料）

  • 金属基元件
  • 基于聚合物的设备

第 11 章尿道结石管理设备市场（依应用）

  • 膀胱结石
  • 肾结石
  • 输尿管结石

第 12 章尿道结石管理设备市场（依最终用户）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十三章尿道结石管理设备市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章尿道结石管理设备市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。尿道结石管理设备市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Advanced MedTech Holdings
    • AKSM, Ltd.
    • Avvio Medical, Inc.
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • Calyxo Inc.
    • Coloplast A/S
    • Cook Group Incorporated
    • DirexGroup
    • Dornier MedTech GmbH
    • Dyne Medical Group Inc.
    • EMS Electro Medical Systems SA
    • EDAP TMS SA
    • Elmed Lithotripsy Systems
    • EndoTheia, Inc.
    • Karl Storz GmbH & Co. KG
    • Nissha Medical Technologies
    • Olympus Corporation
    • Quanta System SpA
    • Richard Wolf GmbH
    • Siemens Healthineers
    • SonoMotion
    • Teleflex Incorporated
Product Code: MRR-ED54C46E9009

The Urolithiasis Management Devices Market is projected to grow by USD 903.70 million at a CAGR of 7.93% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 490.76 million
Estimated Year [2025] USD 527.03 million
Forecast Year [2032] USD 903.70 million
CAGR (%) 7.93%

A comprehensive introduction that frames current clinical practices, technological innovation, and stakeholder pressures shaping urolithiasis device development and adoption

Urolithiasis management devices occupy a dynamic intersection of engineering innovation, evolving clinical protocols, and shifting care delivery models. Over the past decade, incremental improvements in imaging, endoscopic visualization, and intracorporeal energy delivery have converged to expand treatment options and refine patient pathways. This introduction synthesizes the current landscape by highlighting how device design, material science, and procedural ergonomics are increasingly tailored to minimize invasiveness while optimizing stone clearance and patient recovery.

Clinicians now prioritize devices that offer reproducible outcomes with predictable safety profiles, and manufacturers respond by focusing on modularity, single-use options, and integration with digital platforms for procedural guidance. Payers and health systems demand demonstrable improvements in throughput and post-procedure resource utilization, which in turn shapes procurement preferences. In sum, the sector is characterized by rapid technical iteration, growing emphasis on user experience, and a continuous recalibration of value propositions to meet clinical and economic performance requirements.

Illustration of transformative shifts driven by device miniaturization, disposable technologies, and integrated digital platforms reshaping procedural pathways and adoption

The landscape of urolithiasis management is undergoing transformative shifts driven by advances in device miniaturization, energy delivery modalities, and integration of digital diagnostics. Miniaturized ureteroscopes and flexible endoscopes are widening the spectrum of stones that can be managed endoscopically, reducing reliance on more invasive procedures. Concurrently, enhancements in intracorporeal lithotripsy-particularly the refinement of laser platforms that balance fragmentation efficiency with thermal safety-have altered procedural algorithms, increasing case volumes that can be completed in ambulatory settings.

Beyond pure device performance, there is a pronounced movement toward disposability and single-use technologies to address infection control concerns and streamline sterilization workflows. The rise of data-enabled devices that provide procedural analytics and imaging enhancement tools is creating opportunities for outcome tracking and operator training. Moreover, regulatory expectations and reimbursement frameworks are evolving in tandem, encouraging manufacturers to demonstrate not only clinical efficacy but also measurable operational benefits, which reshapes product positioning and commercialization strategies.

Analysis of how evolving tariff regimes and trade realignments in 2025 are influencing sourcing strategies, cost structures, and procurement resilience across the device supply chain

Tariff policy changes and international trade dynamics in 2025 have introduced new operational considerations for manufacturers, suppliers, and healthcare purchasers. Increased duties on specific medical device components, coupled with supply chain realignments catalyzed by geopolitical developments, have compelled stakeholders to reassess sourcing strategies and cost structures. Importantly, these trade measures have emphasized the need for resilient procurement frameworks that account for variable cross-border costs and lead times.

In response, many organizations are diversifying supplier bases and evaluating nearshoring opportunities to mitigate exposure to import-related volatility. Device designers are also reconsidering bill-of-materials choices, favoring materials and subcomponents that are locally available or subject to lower trade barriers. For clinical providers, procurement teams are increasingly incorporating total-cost-of-ownership analyses that account for tariff impacts, logistics, and inventory buffers, thereby influencing purchasing cycles and contractual arrangements with manufacturers and distributors.

Deep segmentation insights that connect device types, treatment modalities, materials, clinical applications, and end-user requirements to strategic product positioning

Effective segmentation analysis illuminates where clinical need, technology fit, and purchasing behavior intersect. Based on Device Type, the landscape is studied across Guidewires, Lithotripters, Stents, and Ureteroscopes, revealing distinct development trajectories: guidewires emphasize tip control and coating technology, lithotripters pursue energy-efficient fragmentation with minimal collateral tissue effect, stents optimize patient comfort and encrustation resistance through material science, and ureteroscopes balance optics with flexibility and durability. Based on Treatment Type, the market is studied across Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, and Percutaneous Nephrolithotomy, and each modality drives unique device requirements related to energy delivery, access instrumentation, and imaging integration.

Based on Device Material, the market is studied across Metal-Based Devices and Polymer-Based Devices, which underlines trade-offs between strength, flexibility, cost, and biocompatibility that influence clinical selection and lifecycle management. Based on Application, the market is studied across Bladder Stones, Kidney Stones, and Ureteral Stones, highlighting how stone location dictates access strategy, instrument size, and post-procedural follow-up. Finally, based on End User, the market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics, with each setting prioritizing different value drivers such as throughput, device turnaround time, or procedural complexity. Taken together, these segmentation lenses provide a multi-dimensional view that informs product development priorities and commercialization tactics.

Key regional considerations outlining how divergent regulatory, reimbursement, and clinical practice environments across major geographies shape device adoption and commercialization

Regional dynamics influence clinical practice patterns, regulatory pathways, and reimbursement landscapes, which in turn shape device design and go-to-market strategies. In the Americas, health systems exhibit a high adoption rate of minimally invasive techniques and place strong emphasis on evidence demonstrating operational efficiency and patient-centered outcomes, prompting vendors to support health economic narratives alongside clinical data. Procurement cycles in this region are often influenced by integrated delivery networks and group purchasing organizations, which amplifies the importance of scalable supply models and service support.

In Europe, Middle East & Africa, heterogeneity in regulatory expectations and payer structures requires adaptable market entry strategies that balance localized clinical validation with flexible commercial models. Stakeholders in this region may prioritize cost-effectiveness and durability, especially in systems with constrained capital allocation. Within the Asia-Pacific region, rapid infrastructure development and high procedure volumes create significant demand for cost-effective, scalable devices and single-use solutions that address infection control and throughput. Across all regions, partnerships with local distributors and targeted clinician engagement remain central to adoption and long-term market development.

Critical competitive insights into how established players and agile innovators are differentiating through product design, service models, and strategic partnerships

The competitive landscape comprises established device manufacturers, innovative medtech startups, and specialized component suppliers, each pursuing differentiated strategies to capture clinical preference and procurement attention. Leading product development teams focus on aligning design features with clinician workflows, emphasizing ergonomics, intuitive controls, and interoperability with imaging systems. Contracting and post-market support capabilities increasingly differentiate suppliers, as hospitals and surgical centers seek partners that provide training, maintenance, and data analytics to optimize utilization.

Concurrently, some companies are adopting focused plays-such as single-use platforms or high-powered laser systems-while others concentrate on incremental improvements to guidewires and stents through advanced materials. Strategic alliances, licensing arrangements, and targeted acquisitions are common tactics used to accelerate capability expansion, particularly in areas like imaging integration and disposable instrument portfolios. Ultimately, companies that combine clinical credibility, supply resilience, and compelling value demonstrations are positioned to lead in a landscape that prizes both innovation and operational performance.

Actionable recommendations that align product design, manufacturing agility, supply chain resilience, and evidence generation to accelerate clinical adoption and commercial success

Industry leaders should adopt a multi-pronged approach that aligns R&D priorities with real-world clinical workflows and procurement demands. First, prioritize human-centered design to reduce procedure time and improve user ergonomics, ensuring that new devices integrate seamlessly with existing imaging and navigation systems. Second, invest in modular and scalable manufacturing strategies that allow rapid shifts between reusable and single-use production pathways, thereby responding to infection control concerns and procurement preferences.

Third, strengthen supply chain resilience by diversifying suppliers, evaluating nearshoring opportunities, and embedding tariff and logistics scenarios into commercial planning. Fourth, cultivate robust clinical evidence and health economic dossiers that speak directly to institutional decision-makers, demonstrating not only clinical outcomes but also downstream operational benefits. Lastly, pursue targeted partnerships with regional distributors and training centers to accelerate adoption, while offering post-sale analytics and education services that support sustained utilization and long-term customer relationships.

A transparent mixed-methods research methodology integrating clinician interviews, technical literature review, and scenario analysis to validate trends and implications

This research synthesis is built on a mixed-methods approach that triangulates primary qualitative engagement with secondary public domain sources and technical literature. Primary inputs included structured interviews with clinicians across key specialties, procurement leads from diverse care settings, and industry executives to validate technology trends and identify operational pain points. Secondary research encompassed peer-reviewed clinical studies, regulatory filings, device technical specifications, and publicly available guidance from professional societies to ensure technical accuracy and context.

Analytical methods combined thematic coding of qualitative interviews with cross-sectional comparison of device features and clinical application requirements. Where applicable, supply chain and policy impacts were assessed through scenario analysis to understand sensitivity to trade and logistics variables. Throughout, findings were corroborated across multiple sources to strengthen validity and presented with transparency about data provenance and methodological limits so that decision-makers can interpret insights with appropriate confidence.

Concluding synthesis highlighting the convergence of clinical innovation, operational realities, and strategic imperatives that will define future progress in urolithiasis device management

The management of urolithiasis is at an inflection point where iterative device innovation, procedural evolution, and supply chain complexities converge to redefine clinical pathways. Advances in scope flexibility, energy delivery, and single-use technologies are expanding minimally invasive options and supporting shifts toward ambulatory care. Meanwhile, trade dynamics and regional heterogeneity necessitate more sophisticated procurement strategies and localized commercialization approaches. Decision-makers must therefore balance the promise of technological improvements with pragmatic considerations around supply resilience and evidence-backed value.

Moving forward, stakeholders who successfully align product development with clinician workflows, invest in demonstrable outcome metrics, and build flexible manufacturing and distribution models will capture the greatest opportunity to influence care delivery. The convergence of clinical needs, regulatory expectations, and operational priorities creates fertile ground for innovations that are not only clinically superior but also operationally compelling, ultimately improving patient outcomes and health system efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing integration of artificial intelligence algorithms for automated kidney stone detection and treatment planning
  • 5.2. Surge in demand for single-use disposable ureteroscopes to reduce cross-contamination risks
  • 5.3. Advancements in ultrasonic and laser lithotripsy technologies for faster stone fragmentation
  • 5.4. Expansion of telemedicine and remote patient monitoring for post-operative urolithiasis care
  • 5.5. Development of bioresorbable stents to minimize patient discomfort and reduce secondary procedures
  • 5.6. Rising investments in portable ultrasound-guided lithotripsy devices for point-of-care applications
  • 5.7. Increasing focus on personalized treatment pathways through 3D-printed patient-specific kidney models

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urolithiasis Management Devices Market, by Device Type

  • 8.1. Guidewires
  • 8.2. Lithotripters
  • 8.3. Stents
  • 8.4. Ureteroscopes

9. Urolithiasis Management Devices Market, by Treatment Type

  • 9.1. Extracorporeal Shock Wave Lithotripsy
  • 9.2. Intracorporeal Lithotripsy
  • 9.3. Percutaneous Nephrolithotomy

10. Urolithiasis Management Devices Market, by Device Material

  • 10.1. Metal-Based Devices
  • 10.2. Polymer-Based Devices

11. Urolithiasis Management Devices Market, by Application

  • 11.1. Bladder Stones
  • 11.2. Kidney Stones
  • 11.3. Ureteral Stones

12. Urolithiasis Management Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Urolithiasis Management Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Urolithiasis Management Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Urolithiasis Management Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Advanced MedTech Holdings
    • 16.3.2. AKSM, Ltd.
    • 16.3.3. Avvio Medical, Inc.
    • 16.3.4. Becton, Dickinson and Company
    • 16.3.5. Boston Scientific Corporation
    • 16.3.6. Calyxo Inc.
    • 16.3.7. Coloplast A/S
    • 16.3.8. Cook Group Incorporated
    • 16.3.9. DirexGroup
    • 16.3.10. Dornier MedTech GmbH
    • 16.3.11. Dyne Medical Group Inc.
    • 16.3.12. E.M.S. Electro Medical Systems S.A.
    • 16.3.13. EDAP TMS SA
    • 16.3.14. Elmed Lithotripsy Systems
    • 16.3.15. EndoTheia, Inc.
    • 16.3.16. Karl Storz GmbH & Co. KG
    • 16.3.17. Nissha Medical Technologies
    • 16.3.18. Olympus Corporation
    • 16.3.19. Quanta System S.p.A.
    • 16.3.20. Richard Wolf GmbH
    • 16.3.21. Siemens Healthineers
    • 16.3.22. SonoMotion
    • 16.3.23. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 224. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 225. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 248. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 249. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 260. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 261. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 272. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 273. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 284. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 285. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 294. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 295. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARK